m6A Reader YTHDC1 Impairs Respiratory Syncytial Virus Infection by Downregulating Membrane CX3CR1 Expression

Author:

Picavet Lucas W.1,van Vroonhoven Ellen C. N.1ORCID,Scholman Rianne C.1,Smits Yesper T. H.1,Banerjee Rupa23,Besteman Sjanna B.1,Viveen Mattheus C.1,van der Vlist Michiel M.13ORCID,Tanenbaum Marvin E.234,Lebbink Robert J.5ORCID,Vastert Sebastiaan J.1ORCID,van Loosdregt Jorg1

Affiliation:

1. Center for Translational Immunology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands

2. Hubrecht Institute-KNAW and University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands

3. Oncode Institute, 3584 CX Utrecht, The Netherlands

4. Department of Bionanoscience, Delft University of Technology, 2600 AA Delft, The Netherlands

5. Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands

Abstract

Respiratory syncytial virus (RSV) is the most prevalent cause of acute lower respiratory infection in young children. Currently, the first RSV vaccines are approved by the FDA. Recently, N6-methyladenosine (m6A) RNA methylation has been implicated in the regulation of the viral life cycle and replication of many viruses, including RSV. m6A methylation of RSV RNA has been demonstrated to promote replication and prevent anti-viral immune responses by the host. Whether m6A is also involved in viral entry and whether m6A can also affect RSV infection via different mechanisms than methylation of viral RNA is poorly understood. Here, we identify m6A reader YTH domain-containing protein 1 (YTHDC1) as a novel negative regulator of RSV infection. We demonstrate that YTHDC1 abrogates RSV infection by reducing the expression of RSV entry receptor CX3C motif chemokine receptor 1 (CX3CR1) on the cell surface of lung epithelial cells. Altogether, these data reveal a novel role for m6A methylation and YTHDC1 in the viral entry of RSV. These findings may contribute to the development of novel treatment options to control RSV infection.

Funder

ReumaNederland

Publisher

MDPI AG

Reference44 articles.

1. Deaths from RSV in young infants—The hidden community burden;Cohen;Lancet Glob. Health,2022

2. Respiratory Syncytial Virus Infection: An Update;Soni;Indian J. Pediatr.,2023

3. Respiratory syncytial virus infection and novel interventions;Langedijk;Nat. Rev. Microbiol.,2023

4. (2023). U.S. FDA Approves ABRYSVOTM Pfizer’s Vaccine for the Prevention of Respiratory Syncytial Virus (RSV) in Older Adults, Pfizer, Inc.

5. Heparin-Dependent Attachment of Respiratory Syncytial Virus (RSV) to Host Cells;Krusat;Arch. Virol.,1997

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3